Cyclooxygenase-2 inhibitors and prostate cancer.
James
Nicholas
N
D002986:Clinical Trials as Topic; D051546:Cyclooxygenase 2 / Q000502:physiology; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000532:radiotherapy
D052246:Cyclooxygenase 2 Inhibitors; D051546:Cyclooxygenase 2